Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier

Hearing Research

Volumn 272, Issue 1-2, 2011, Pages 168-177

  Havenith, Sarah ^a   Versnel, Huib ^a   Agterberg, Martijn J H ^a,b   de Groot, John C M J ^a   Sedee, Robert Jan ^a   Grolman, Wilko ^a   Klis Sjaak F L , S F L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GELFOAM; NEUROTROPHIN; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; CELL SHAPE; CELL SIZE; CELL SURVIVAL; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRODE; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GUINEA PIG; HEARING IMPAIRMENT; HISTOLOGY; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; SPIRAL GANGLION;

ACOUSTIC STIMULATION; ANIMALS; AUDITORY THRESHOLD; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SHAPE; CELL SIZE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG CARRIERS; ELECTRIC STIMULATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; FUROSEMIDE; GELATIN SPONGE, ABSORBABLE; GUINEA PIGS; HEARING LOSS; KANAMYCIN; NEUROPROTECTIVE AGENTS; SPIRAL GANGLION; TIME FACTORS;

EID: 79851515980     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2010.10.003     Document Type: Article

References (57)

1. Agterberg M.J.H., Versnel H., De Groot J.C.M.J., Smoorenburg G.F., Albers F.W.J., Klis S.F.L. Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear. Res. 2008, 224:25-34.
2. Agterberg M.J.H., Versnel H., Van Dijk L.M., De Groot J.C.M.J., Klis S.F.L. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J. Assoc. Res. Otolaryngol. 2009, 10:355-367.
3. Boleas-Aguirre M.S., Lin F.R., Della Santina C.C., Minor L.B., Carey L.P. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol. Neurotol. 2008, 29:33-38.
4. Chikar J.A., Colesa D.J., Swiderski D.L., Polo A.D., Raphael Y., Pfingst B.E. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear. Res. 2008, 245:24-34.
5. De Groot J.C.M.J., Veldman J.E., Huizing E.H. An improved fixation method for guinea pig cochlear tissues. Acta Otolaryngol. 1987, 104:234-242.
6. Endo T., Nakagawa T., Kita T., Iguchi F., Kim T., Tamura T., Iwai K., Tabata Y., Ito J. Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005, 115:2016-2020.
7. Ernfors P., Van De Water T., Loring J., Jaenisch R. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 1995, 14:1153-1164.
8. Ernfors P., Duan M.L., El Shamy W.M., Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat. Med. 1996, 2:463-467.
9. Fritzsch B., Pirvola U., Ylikoski J. Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications. Cell Tissue Res. 1999, 295:369-382.
10. Fritzsch B., Tessarollo L., Coppola E., Reichardt L.F. Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidance. Prog. Brain Res. 2004, 146:265-278.
11. Garduno-Anaya M.A., Couthino De Toledo H., Hinojosa-Gonzalez R., Pane-Pianese C., Ríos-Castañeda L.C. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol. Head Neck Surg. 2005, 133:285-294.
12. Ghiz A.F., Salt A.N., DeMott J.E., Henson M.M., Henson W.O., Gewalt S.L. Quantitative anatomy of the round window and cochlear aqueduct in guinea pigs. Hear. Res. 2001, 162:105-112.
13. Gillespie L.N., Clark G.M., Bartlett P.F., Marzella P.L. BDNF-induced survival of auditory neurons in vivo: cessation of treatment leads to accelerated loss of survival effects. J. Neurosci. Res. 2003, 71:785-790.
14. Gillespie L.N., Clark G.M., Marzella P.L. Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport 2004, 15:1121-1125.
15. Glueckert R., Bitsche M., Miller J.M., Zhu Y., Prieskorn D.M., Altschuler R.A., Schrott-Fischer A. Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J. Comp. Neurol. 2008, 507:1602-1621.
16. Goycoolea M.V., Lundman L. Round window membrane. Structure, function and permeability: a review. Microsc. Res. Tech. 1997, 36:201-211.
17. Guitton M.J., Caston J., Ruel J., Johnson R.M., Pujol R., Puel J. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J. Neurosci. 2003, 23:3944-3952.
18. Hall R.D. Estimation of surviving spiral ganglion cells in the deaf rat using the electrically evoked auditory brainstem response. Hear. Res. 1990, 45:123-136.
19. Ito J., Endo T., Nakagawa T., Kita T., Kim T.S., Iguchi F. A new method for drug application to the inner ear. ORL J. Otorhinolaryngol. Relat. Spec. 2005, 67:272-275.
20. Klis S.F.L., O'Leary S.J., Hamers F.P.T., De Groot J.C.M.J., Smoorenburg G.F. Reversible cisplatin ototoxicity in the albino guinea pig. Neuroreport 2000, 11:623-626.
21. Lalwani A.K., Han J.J., Castelein C.M., Carvalho G.J., Mhathre A.N. In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 2002, 112:1325-1334.
22. Leake P.A., Hradek G.T., Snyder R.L. Chronic electrical stimulation by a cochlear implant promotes survival of spiral ganglion neurons after neonatal deafness. J. Comp. Neurol. 1999, 412:543-562.
23. Lefebvre P.P., Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol. 2002, 122:698-702.
24. Maruyama J., Yamagata T., Ulfendahl M., Bredberg G., Altschuler R.A., Miller J.M. Effects of antioxidants on auditory nerve function and survival in deafened guinea pigs. Neurobiol. Dis. 2007, 25:309-318.
25. Maruyama J., Miller J.M., Ulfendahl M. Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness. Neurobiol. Dis. 2008, 29:14-21.
26. McCall A.A., Swan E.E., Borenstein J.T., Sewell W.F., Kujawa S.G., McKenna M.J. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear. 2010, 31:156-165.
27. McGuinness S.L., Shepherd R.K. Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol. Neurotol. 2005, 26(5):1064-1072.
28. Mikulec A., Plontke S.K., Hartsock J., Salt A.N. Entry of substances into perilymph trough the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol. Neurotol. 2009, 30:131-138.
29. Miller J.M., Chi D.H., O'Keeffe L.J., Kruszka P., Raphael Y., Altschuler R.A. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int. J. Dev. Neurosci. 1997, 15:631-643.
30. Miller J.M., Le Prell C.G., Prieskorn D.M., Wys N.L., Altschuler R.A. Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J. Neurosci. Res. 2007, 85:1959-1969.
31. Mitchell A., Miller J.M., Finger P.A., Heller J.W., Raphael Y., Altschuler R.A. Effects of chronic high-rate electrical stimulation on the cochlea and eighth nerve in the deafened guinea pig. Hear. Res. 1997, 105:30-43.
32. Nakaizumi T., Kawamoto K., Minoda R., Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol. Neurootol. 2004, 9:135-143.
33. Noushi F., Richardson R.T., Hardman J., Clark G., O'Leary S. Delivery of neurotrophin-3 to the cochlea using alginate beads. Otol. Neurotol. 2005, 26:528-533.
34. Pettingill L.N., Richardson R.T., Wise A.K., O'Leary S., Shepherd R.K. Neurotrophic factors and neural prostheses: Potential clinical applications based upon findings in the auditory system. IEEE Trans. Biomed. Eng. 2007, 54:1138-1148.
35. Rejali D., Lee V.A., Abrashkin K.A., Humayun N., Swiderski D.L., Raphael Y. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear. Res. 2007, 228:180-187.
36. Richardson R.T., O'Leary S., Wise A., Hardman J., Clark G. A single dose of neurotrophin-3 to the cochlea surrounds spiral ganglion neurons and provides trophic support. Hear. Res. 2005, 204:37-47.
37. Richardson R.T., Noushi F., O'Leary S. Inner ear therapy for neural preservation. Audiol. Neurootol. 2006, 11:343-356.
38. Richardson R.T., Wise A.K., Thompson B.C., Flynn B.O., Atkinson P.J., Fretwell N.J., Fallon J.B., Wallace G., Shepherd R.K., Clark G.M., O'Leary S. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 2009, 30:2614-2624.
39. Saber A., Laurell G., Bramer T., Edsman K., Engmer C., Ulfendahl M. Middle ear application of a sodium hyaluronate gel loaded with neomycin in a guinea pig model. Ear Hear. 2009, 30:81-89.
40. Sajjadi H., Paparella M.M. Meniere's disease. Lancet 2008, 372:406-414.
41. Salt A.N., Ma Y. Quantification of solute entry into cochlear perilymph through the round window membrane. Hear. Res. 2001, 154:88-97.
42. Salt A.N., Plontke S.K. Principles of local drug delivery to the inner ear. Audiol. Neurootol. 2009, 14:350-360.
43. Scheper V., Paasche G., Miller J.M., Warnecke A., Berkingali N., Lenarz T., Stöver T. Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion cell survival in deafened guinea pigs. J. Neurosci. Res. 2009, 87:1389-1399.
44. Shepherd R.K., Coco A., Epp S.B., Crook J.M. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J. Comp. Neurol. 2005, 486:145-158.
45. Shinohara T., Bredberg G., Ulfendahl M., Pyykko I., Olivius N.P., Kaksonen R., Lindstrom B., Altschuler R., Miller J.M. Neurotrophic factor intervention restores auditory function in deafened animals. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1657-1660.
46. Silverstein H., Arruda J., Rosenberg S.I., Deems D., Hester T.O. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol. Head Neck Surg. 1999, 120:649-655.
47. Silverstein H., Choo D., Rosenberg S.I., Kuhn J., Seidman M., Stein I. Intratympanic steroid treatment of inner ear disease and tinnitus. Ear Nose Throat J. 1996, 75:468-488.
48. Slattery W.H., Fisher L.M., Iqbal Z., Friedman R.A., Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol. Head Neck Surg. 2005, 133:251-259.
49. Sly D.J., Heffer L.F., White M.W., Shepherd R.K., Birch M.G., Minter R.L., Nelson N.E., Wise A.K., O'Leary S.J. Deafness alters auditory nerve fiber responses to cochlear implant stimulation. Eur. J. Neurosci. 2007, 26:510-522.
50. Smith L., Simmons F.B. Estimating eighth nerve survival by electrical stimulation. Ann. Otol. Rhinol. Laryngol. 1983, 92:19-23.
51. Staecker H., Kopke R., Malgrange B., Lefebvre P., Van De Water T.R. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996, 7:889-894.
52. Staecker H., Gabaizadeh R., Federoff H., Van De Water T.R. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol. Head Neck Surg. 1998, 119:7-13.
53. Van den Honert C., Stypulkowski P.H. Single fiber mapping of spatial excitation patterns in the electrically stimulated auditory nerve. Hear. Res. 1987, 29:195-206.
54. Versnel H., Agterberg M.J.H., De Groot J.C.M.J., Smoorenburg G.F., Klis S.F.L. Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear. Res. 2007, 231:1-12.
55. West B.A., Brummett R.E., Himes D.L. Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch. Otolaryngol. 1973, 98:32-37.
56. Wise A.K., Richardson R., Hardman J., Clark G., O'Leary S. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J. Comp. Neurol. 2005, 487:147-165.
57. Yamagata T., Miller J.M., Ulfendahl M., Olivius N.P., Altschuler R.A., Pyykkö I., Bredberg G. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J. Neurosci. Res. 2004, 78:75-86.